Fenix Pharma
PrivateLast Round
Debt
May 1, 2024
Total Funding Raised
$1.13M
Company Overview
Fenix Pharma is a pharmaceutical cooperative company that distributes medicines, medical devices, and dietary supplements across various therapeutic areas including gastroenterology, musculoskeletal health, and otorhinolaryngology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Pharma Supply Chain
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fenix Pharma Comps
Public and private peers based on sector, stage, and business model.
Fenix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 1, 2024 | ||||
| Buyout/LBO | Sep 1, 2011 |
Fenix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fin4Coop | Debt |
| Coopfond | Buyout/LBO, Debt |
| CFI - Cooperazione Finanza Impresa | Buyout/LBO, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors increased 31% MoM.
- May 1, 2024
$1.13M debt round closed with CFI, Coopfond, and Fin4Coop.
Fenix Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fenix Pharma's valuation, stock price, and market status.
